Alzheimer's Prevention: The Evidence-Based Case for Aggressive Early Action Starting Today
Alzheimer's disease develops for years before symptoms appear, and part of the risk comes from things people can change. After accounting for the overlap between risk factors, one analysis estimated that around a third of Alzheimer's cases worldwide might be attributable to seven modifiable risk factors.[2] Prevention trials have had mixed results,[4,10,11] but the evidence still points to steps worth taking.
- After adjusting for the overlap between risk factors, around a third of Alzheimer's cases worldwide might be attributable to seven modifiable risk factors: low education, physical inactivity, smoking, depression, midlife high blood pressure, midlife obesity and diabetes.[2]
- By the time the first symptoms appear, amyloid build-up is close to its peak and tau pathology is often already present, so the years before symptoms are the window for prevention.[7]
- In the FINGER trial, a two-year program of diet, exercise, cognitive training and vascular risk monitoring produced a small but statistically significant cognitive benefit in at-risk older adults; similar trials in France and the Netherlands did not show clear benefits.[4,10,11]
- Hearing aid users had a 19% lower risk of long-term cognitive decline in mostly observational studies, but in the ACHIEVE trial a hearing intervention did not slow decline overall, though it may help people at higher risk.[3,12]
- APOE4 is the main genetic risk factor: in a Danish cohort, people with two copies had a 10-year Alzheimer's risk of 7% (women) and 6% (men) at ages 60 to 69, rising to 24% and 19% at 80 and older.[6]
Researchers now define Alzheimer's disease by its underlying biology rather than its symptoms. The 2018 NIA-AA research framework classifies the disease using biomarkers of amyloid deposition, pathologic tau and neurodegeneration (the AT(N) system), and is intended for research rather than routine clinical care.[1] The changes build up silently: by the time the earliest symptoms appear, amyloid build-up is close to its peak and tau pathology is often already present, which makes the symptom-free years the window for prevention.[7]
That is why prevention research looks well before old age: several of the risk factors below, including high blood pressure and obesity, count most in midlife.[2]
Modifiable Risk Factors: How Much Could Prevention Do?
A widely cited analysis combined relative risks from meta-analyses for seven modifiable risk factors: diabetes, midlife high blood pressure, midlife obesity, physical inactivity, depression, smoking and low education. Treated as independent, they accounted for about half of Alzheimer's cases worldwide, but after adjusting for the overlap between them the estimate fell to 28%, around a third of cases, and to about 30% in the US, Europe and the UK.[2] Low education carried the largest share worldwide and physical inactivity the largest in the US, Europe and the UK. These estimates assume that the risk factors cause the disease.[2]
Hearing loss is one of the most studied newer risk factors. A 2023 meta-analysis covering more than 137,000 participants found that hearing aid users had a 19% lower risk of long-term cognitive decline than people with uncorrected hearing loss; most of the evidence was observational, and the authors called for randomized trials.[3] The largest such trial, ACHIEVE, randomized 977 adults aged 70 to 84 with untreated hearing loss to hearing aids and counselling or to health education. Over three years, cognitive decline did not differ between the groups overall, but the effect differed between higher-risk participants and healthier volunteers, suggesting that hearing treatment might slow decline in people at greater risk.[12]
The FINGER Trial and What Followed
The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) randomized 1,260 adults aged 60 to 77 at raised dementia risk to a two-year program of diet, exercise, cognitive training and vascular risk monitoring, or to general health advice. Cognitive test scores improved slightly more in the intervention group: the difference was 0.022 per year on a composite score, small but statistically significant. Adverse events, mostly musculoskeletal pain, were more common with the intervention (7% versus 1%).[4]
Two larger trials have since tested the approach elsewhere. US POINTER enrolled 2,111 sedentary adults aged 60 to 79 at higher risk of cognitive decline at 5 US sites. Both groups were encouraged to be more active, eat better and stay socially and mentally engaged, but one followed a structured, supported program and the other a self-guided one. Over 2 years, cognitive scores rose in both groups, slightly faster with the structured program (by 0.029 standard deviations a year).[14] LatAm-FINGERS adapted the program for 1,065 at-risk adults in 11 Latin American countries and found a larger advantage for the structured intervention over health advice (0.11 standard deviations a year); serious adverse events were more frequent in the structured group, but none were judged related to the intervention.[15] The effects on test scores are modest, and whether they translate into less dementia over the long term is not yet known.
Similar trials have not consistently confirmed that result. In France, MAPT gave 1,680 adults aged 70 or older with memory complaints, limits in daily activities or slow walking a multidomain program, omega-3 supplements, both or placebo; none of these significantly changed cognitive decline over three years.[10] In the Netherlands, preDIVA's six-year nurse-led vascular care program for 3,526 people aged 70 to 78 did not reduce dementia (7% in both groups), possibly because participants' cardiovascular risk was modest and usual care was already good.[11]
APOE4: Understanding Your Genetic Risk
APOE (apolipoprotein E) is the main cholesterol carrier in the brain and comes in three common variants. Compared with the common ε3 form, ε4 increases the risk of Alzheimer's disease and ε2 lowers it; the variants differ in how they regulate the clumping and clearance of amyloid-beta.[5]
Absolute risks put the genetics in perspective. Among more than 104,000 Danes, people with two copies of ε4 had a 10-year risk of Alzheimer's disease of 7% (women) and 6% (men) at ages 60 to 69, 16% and 12% at 70 to 79, and 24% and 19% at 80 and older, 8.7 times the risk of people with two ε3 copies.[6]
Whether to test for APOE is a personal decision. Knowing your genotype can inform how you weigh prevention, but genetic results can carry a psychological burden and, in some places, insurance implications. A high-risk genotype is also not a diagnosis: even at 80 and older, about three in four people with two ε4 copies in the Danish study did not develop Alzheimer's disease within 10 years.[6] Genetic counselling before testing can help.
The Prevention Protocol
Get Your Hearing Checked and Treat Any Loss
If conversations are getting harder to follow, get your hearing tested. Hearing aid use is linked to slower cognitive decline in observational studies,[3] and in the ACHIEVE trial any benefit appeared in people at higher risk of decline rather than in healthier volunteers.[12]
Prioritize Sleep Architecture — Not Just Duration
In older adults, less deep (slow-wave) sleep was associated with more Alzheimer's pathology, particularly tau. The study was observational, so it does not show that improving sleep lowers risk.[7] If you snore heavily or wake unrefreshed, ask your doctor about a sleep study.
Exercise Aerobically
In a randomized trial of 120 older adults, aerobic exercise training increased the size of the hippocampus, a memory centre that shrinks in late adulthood, by about 2%, effectively reversing one to two years of age-related loss, and improved spatial memory; larger gains went with higher levels of BDNF.[8]
Manage Blood Pressure and Vascular Risk
Blood pressure is the best-tested vascular target. In SPRINT MIND, 9,361 adults with high blood pressure were treated to a systolic goal below 120 or below 140 mm Hg. The intensive goal significantly reduced mild cognitive impairment; the smaller reduction in probable dementia was not statistically significant, possibly because the trial stopped early.[13] Midlife high blood pressure, midlife obesity and diabetes are among the risk factors in estimates of preventable cases.[2]
Maintain Social Engagement and Cognitive Stimulation
A review of long-term studies found that social, mentally stimulating and physical activities were each associated with better cognition and lower dementia risk, and concluded that an active, socially integrated lifestyle in later life protects against dementia; the evidence comes from observational studies.[9]
Put this research into practice: Gene Variant Lookup
References
- 1Jack CR Jr, et al. "NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease." Alzheimers Dement. 2018;14(4):535-562. PubMed · DOI
- 2Norton S, et al. "Potential for primary prevention of Alzheimer's disease: an analysis of population-based data." Lancet Neurol. 2014;13(8):788-94. PubMed · DOI
- 3Yeo BSY, et al. "Association of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis." JAMA Neurol. 2023;80(2):134-141. PubMed · DOI
- 4Ngandu T, et al. "A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial." Lancet. 2015;385(9984):2255-63. PubMed · DOI
- 5Liu CC, et al. "Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy." Nat Rev Neurol. 2013;9(2):106-18. PubMed · DOI
- 6Rasmussen KL, et al. "Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study." CMAJ. 2018;190(35):E1033-E1041. PubMed · DOI
- 7Lucey BP, et al. "Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease." Sci Transl Med. 2019;11(474). PubMed · DOI
- 8Erickson KI, et al. "Exercise training increases size of hippocampus and improves memory." Proc Natl Acad Sci U S A. 2011;108(7):3017-22. PubMed · DOI
- 9Fratiglioni L, et al. "An active and socially integrated lifestyle in late life might protect against dementia." Lancet Neurol. 2004;3(6):343-53. PubMed · DOI
- 10Andrieu S, et al. "Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial." Lancet Neurol. 2017;16(5):377-389. PubMed · DOI
- 11Moll van Charante EP, et al. "Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial." Lancet. 2016;388(10046):797-805. PubMed · DOI
- 12Lin FR, et al. "Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial." Lancet. 2023;402(10404):786-797. PubMed · DOI
- 13Williamson JD, et al. "Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial." JAMA. 2019;321(6):553-561. PubMed · DOI
- 14Baker LD, et al. "Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial." JAMA. 2025;334(8):681-691. PubMed · DOI
- 15Crivelli L, et al. "Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial." Lancet. 2026;408(10553):417-429. PubMed · DOI